Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound

Susan A. Charman, William N. Charman, Mark C. Rogge, Terry D. Wilson, Frank J. Dutko, Colin W. Pouton

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Self-emulsifying drug delivery systems (SEDDSs) represent a possible alternative to traditional oral formulations of lipophilic compounds. In the present study, a lipophilic compound, WIN 54954, was formulated in a medium chain triglyceride oil/nonionic surfactant mixture which exhibited self-emulsification under conditions of gentle agitation in an aqueous medium. The efficiency of emulsifi-cation was studied using a laser diffraction sizer to determine particle size distributions of the resultant emulsions. An optimized formulation which consisted of 25% (w/w) surfactant, 40% (w/w) oil, and 35% (w/w) WIN 54954 emulsified rapidly with gentle agitation in 0.1 N HCl (37°C), producing dispersions with mean droplet diameters of less than 3 µm. The self-emulsifying preparation was compared to a polyethylene glycol 600 (PEG 600) solution formulation by administering each as prefilled soft gelatin capsules to fasted beagle dogs in a parallel crossover study. Pharmacokinetic parameters were determined and the absolute bioavailability of the drug was calculated by comparison to an i.v. injection. The SEDDS improved the reproducibility of the plasma profile in terms of the maximum plasma concentration (Cmax) and the time to reach the maximum concentration (tmax). There was no significant difference in the absolute bioavailability of WIN 54954 from either the SEDDS or the PEG formulations.

Original languageEnglish
Pages (from-to)87-93
Number of pages7
JournalPharmaceutical Research
Volume9
Issue number1
DOIs
Publication statusPublished - 1992
Externally publishedYes

Keywords

  • formulation
  • lipophilic drug
  • oral delivery system
  • self-emulsification
  • soft gelatin capsule

Cite this

@article{7ab7aacd25a84b00a08fc60618947e3a,
title = "Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound",
abstract = "Self-emulsifying drug delivery systems (SEDDSs) represent a possible alternative to traditional oral formulations of lipophilic compounds. In the present study, a lipophilic compound, WIN 54954, was formulated in a medium chain triglyceride oil/nonionic surfactant mixture which exhibited self-emulsification under conditions of gentle agitation in an aqueous medium. The efficiency of emulsifi-cation was studied using a laser diffraction sizer to determine particle size distributions of the resultant emulsions. An optimized formulation which consisted of 25{\%} (w/w) surfactant, 40{\%} (w/w) oil, and 35{\%} (w/w) WIN 54954 emulsified rapidly with gentle agitation in 0.1 N HCl (37°C), producing dispersions with mean droplet diameters of less than 3 µm. The self-emulsifying preparation was compared to a polyethylene glycol 600 (PEG 600) solution formulation by administering each as prefilled soft gelatin capsules to fasted beagle dogs in a parallel crossover study. Pharmacokinetic parameters were determined and the absolute bioavailability of the drug was calculated by comparison to an i.v. injection. The SEDDS improved the reproducibility of the plasma profile in terms of the maximum plasma concentration (Cmax) and the time to reach the maximum concentration (tmax). There was no significant difference in the absolute bioavailability of WIN 54954 from either the SEDDS or the PEG formulations.",
keywords = "formulation, lipophilic drug, oral delivery system, self-emulsification, soft gelatin capsule",
author = "Charman, {Susan A.} and Charman, {William N.} and Rogge, {Mark C.} and Wilson, {Terry D.} and Dutko, {Frank J.} and Pouton, {Colin W.}",
year = "1992",
doi = "10.1023/A:1018987928936",
language = "English",
volume = "9",
pages = "87--93",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "American Association of Pharmaceutical Scientists",
number = "1",

}

Self-Emulsifying Drug Delivery Systems : Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound. / Charman, Susan A.; Charman, William N.; Rogge, Mark C.; Wilson, Terry D.; Dutko, Frank J.; Pouton, Colin W.

In: Pharmaceutical Research, Vol. 9, No. 1, 1992, p. 87-93.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Self-Emulsifying Drug Delivery Systems

T2 - Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound

AU - Charman, Susan A.

AU - Charman, William N.

AU - Rogge, Mark C.

AU - Wilson, Terry D.

AU - Dutko, Frank J.

AU - Pouton, Colin W.

PY - 1992

Y1 - 1992

N2 - Self-emulsifying drug delivery systems (SEDDSs) represent a possible alternative to traditional oral formulations of lipophilic compounds. In the present study, a lipophilic compound, WIN 54954, was formulated in a medium chain triglyceride oil/nonionic surfactant mixture which exhibited self-emulsification under conditions of gentle agitation in an aqueous medium. The efficiency of emulsifi-cation was studied using a laser diffraction sizer to determine particle size distributions of the resultant emulsions. An optimized formulation which consisted of 25% (w/w) surfactant, 40% (w/w) oil, and 35% (w/w) WIN 54954 emulsified rapidly with gentle agitation in 0.1 N HCl (37°C), producing dispersions with mean droplet diameters of less than 3 µm. The self-emulsifying preparation was compared to a polyethylene glycol 600 (PEG 600) solution formulation by administering each as prefilled soft gelatin capsules to fasted beagle dogs in a parallel crossover study. Pharmacokinetic parameters were determined and the absolute bioavailability of the drug was calculated by comparison to an i.v. injection. The SEDDS improved the reproducibility of the plasma profile in terms of the maximum plasma concentration (Cmax) and the time to reach the maximum concentration (tmax). There was no significant difference in the absolute bioavailability of WIN 54954 from either the SEDDS or the PEG formulations.

AB - Self-emulsifying drug delivery systems (SEDDSs) represent a possible alternative to traditional oral formulations of lipophilic compounds. In the present study, a lipophilic compound, WIN 54954, was formulated in a medium chain triglyceride oil/nonionic surfactant mixture which exhibited self-emulsification under conditions of gentle agitation in an aqueous medium. The efficiency of emulsifi-cation was studied using a laser diffraction sizer to determine particle size distributions of the resultant emulsions. An optimized formulation which consisted of 25% (w/w) surfactant, 40% (w/w) oil, and 35% (w/w) WIN 54954 emulsified rapidly with gentle agitation in 0.1 N HCl (37°C), producing dispersions with mean droplet diameters of less than 3 µm. The self-emulsifying preparation was compared to a polyethylene glycol 600 (PEG 600) solution formulation by administering each as prefilled soft gelatin capsules to fasted beagle dogs in a parallel crossover study. Pharmacokinetic parameters were determined and the absolute bioavailability of the drug was calculated by comparison to an i.v. injection. The SEDDS improved the reproducibility of the plasma profile in terms of the maximum plasma concentration (Cmax) and the time to reach the maximum concentration (tmax). There was no significant difference in the absolute bioavailability of WIN 54954 from either the SEDDS or the PEG formulations.

KW - formulation

KW - lipophilic drug

KW - oral delivery system

KW - self-emulsification

KW - soft gelatin capsule

UR - http://www.scopus.com/inward/record.url?scp=0026586447&partnerID=8YFLogxK

U2 - 10.1023/A:1018987928936

DO - 10.1023/A:1018987928936

M3 - Article

VL - 9

SP - 87

EP - 93

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 1

ER -